It’s exciting to see a return to normalcy, with industry associations beginning to hold in-person events and conferences. For those of us in the business of pharmacy, the American Pharmacists Association, or APhA, will hold its annual meeting and expo later this month in San Antonio, and I’ll be attending one of the pre-meeting sessions on Thursday, March 17 on behalf of Agilum, now part of The Craneware Group.
The one-day seminar, DigitalHealth.RX 2022, is devoted to the topic of digital health in the pharmacy world and examining the role of real-world data, with presentations devoted to topics such as digitally enabled healthcare, the pharmacist’s role in digital medicine, and how pharmacists can leverage technology to optimize medication management.
Having spent 20 years in clinical pharmacy practice utilizing evidence-based care in various oncology settings, I’m looking forward to learning more about how technology is advancing the field of healthcare by expanding access through technologies like telemedicine and remote medication adherence solutions. Technology is also helping providers to deliver more preventive care and facilitating more open dialogue between patients and caregivers. The seminar will be a great opportunity to learn from speakers and meet and exchange ideas with fellow attendees.
As Agilum’s clinical director of oncology, I assist in the development of pharmacy and analytic services for customers with a heavy focus on the high cost of cancer drugs, helping them determine the best treatment options in terms of clinical efficacy while keeping an eye on reducing cost. Spending on medicines used to treat patients with cancer reached nearly $164 billion globally in 2021, according to a study from the IQVIA Institute, and this figure is projected to rise, highlighting the importance of analytic tools like Agilum’s CRCA™ P&T to help determine the most effective treatment regimens at the lowest possible cost.